| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 25 | ₹14,825 |
| HNI / NII | 68 | 1,700 | ₹10,08,100 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 75,46,376 (50.00%) | — | ₹44,750.01 Cr |
| NII / HNI (Total) | — | 22,63,912 (15.00%) | — | ₹13,425.00 Cr |
| Retail Investors | — | 52,82,462 (35.00%) | — | ₹31,325.00 Cr |
| Total ** | — | 1,50,92,750 (100.00%) | — | ₹895,000.08 Cr |
| Metric | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 130.08 | 511.33 | 465.38 |
| PAT | 31.27 | 138.69 | 133.15 |
| EBITDA | 48.57 | 199.28 | 187.76 |
| Net Worth | 688.32 | 497.53 | 359.07 |
| Total Assets | 922.26 | 717.17 | 513.87 |
| Reserves | 668.52 | 481.11 | 354.59 |
| Borrowings | 135.97 | 135.25 | 75.03 |
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.
The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium
The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors
The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.
Product Portfolio:
As of December 31, 2024, the company had 704 permanent employees.
Competitve Strengths: